Phenotype and genotype analysis for Helicobacter pylori antibiotic resistance in outpatients: a retrospective study
Microbiology Spectrum · 17.10.2023 · 11 (5)
DOI: 10.1128/spectrum.00550-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 17.10.2023. Verfasst von Mengqiu Xiong und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University , Nanjing, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Provincial Key Research and Development Program (Key Technologies R&D Program of Jiangsu Province), Nanjing health science and technology development special fund project plan, The research project of jiangsu health development research center.
Abstract (Originalsprache)
To investigate the antibiotic resistance of Helicobacter pylori ( H. pylori ) in outpatients and to explore the consistency between genotype and phenotype of H. pylori antibiotic resistance. A retrospective study on outpatients screened with urea breath test for H. pylori infection in Nanjing First Hospital from April 2018 to January 2022. Patients who tested positive underwent a consented upper endoscopy, and the H. pylori infection was confirmed by rapid urease test (RUT) and H. pylori culture. For antibiotic resistance phenotype analysis, the H. pylori strains isolated from gastric biopsy were tested for antibiotic resistance phenotype by the Kirby-Bauer disk diffusion test. In addition, the antibiotic resistance genotype of isolated H. pylori was tested with a real-time polymerase chain reaction. A total of 4,399 patients underwent H. pylori infection screening, and 3,306 H. pylori strains were isolated. The antibiotic resistance phenotype test revealed that the resistance rates of metronidazole (MTZ), clarithromycin (CLR), levofloxacin (LEV), amoxicillin (AMX), furazolidone (FR), and tetracycline (TE) were 74.58%, 48.61%, 34.83%, 0.76%, 0.27%, and 0.09%, respectively. Additionally, the antibiotic resistance genotype test revealed that rdxA gene mutation A610G (92.96%), A91G (92.95%), C92A (93.00%), and G392A (95.07%) were predominant in H. pylori with MTZ resistance; 23S rRNA gene mutation A2143G (86.47%) occurred in most H. pylori with CLR resistance; and gyrA gene mutation 87Ile/Lys/Tyr/Arg (97.32%) and 91Asn/Gly/Tyr (90.61%) were the most popular mutations in strains with LEV resistance. The phenotypic resistance and genotypic resistance to CLR (kappa value = 0.824) and LEV (kappa value = 0.895) were in good agreement. The history of eradication with MTZ, CLR, LEV, and AMX was correlated with H. pylori resistance. In short, this study demonstrated that drug resistance of H. pylori was mainly to MTZ, CLR, and LEV in local outpatients. Three drugs can be selected for increased MICs (Minimum Inhibitory Concentration) via single chromosomal mutations. In addition, the genotype could be used to predict the phenotypic H. pylori resistance to CLR and LEV. IMPORTANCE Helicobacter pylori is a key bacterium that causes stomach diseases. There was a high prevalence of H. pylori in the Chinese population. We analyzed the resistance phenotype and genotype characteristics of H. pylori in 4,399 outpatients at the First Hospital of Nanjing, China. We found a higher resistance rate to metronidazole (MTZ) , clarithromycin (CLR), and levofloxacin (LEV), and the genotype could be used to predict the phenotypic H. pylori resistance to CLR and LEV. This study provides information on H. pylori infection and also provides guidance for clinical doctors' drug treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University , Nanjing, China.
- School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University , Nanjing, China.
- Department of Laboratory Medicine, Yangzhou Hongquan Hospital , Yangzhou, China.
- General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University , Nanjing, China.
- Department of Gastroenterology, Nanjing First Hospital, Nanjing Medical University , Nanjing, China.
- H. pylori Research Key Laboratory, Nanjing Medical University , Nanjing, China.
ORCID-Profile: Bangshun He
Förderung
- Jiangsu Provincial Key Research and Development Program (Key Technologies R&D Program of Jiangsu Province)
- Nanjing health science and technology development special fund project plan
- The research project of jiangsu health development research center
Zitieren
APA
Xiong, M., Mohammed Aljaberi, H. S., Khalid Ansari, N., Sun, Y., Yin, S., Nasifu, L., Sun, H., Xu, T., Pan, Y., Nie, Z., Liu, C., Zhang, Z., Jiang, Z., Wang, S., & He, B. (2023). Phenotype and genotype analysis for Helicobacter pylori antibiotic resistance in outpatients: a retrospective study. Microbiology Spectrum, 11(5). https://doi.org/10.1128/spectrum.00550-23
Vancouver
Xiong M, Mohammed Aljaberi HS, Khalid Ansari N, Sun Y, Yin S, Nasifu L, et al. Phenotype and genotype analysis for Helicobacter pylori antibiotic resistance in outpatients: a retrospective study. Microbiology Spectrum. 2023;11(5). doi:10.1128/spectrum.00550-23
BibTeX
@article{Xiong2023,
author = {Xiong, Mengqiu and Mohammed Aljaberi, Hend Sadeq and Khalid Ansari, Nida and Sun, Yalan and Yin, Sijie and Nasifu, Lubanga and Sun, Huiling and Xu, Tao and Pan, Yuqin and Nie, Zhenlin and Liu, Caidong and Zhang, Zhenyu and Jiang, Zongdan and Wang, Shukui and He, Bangshun},
title = {Phenotype and genotype analysis for Helicobacter pylori antibiotic resistance in outpatients: a retrospective study},
journal = {Microbiology Spectrum},
year = {2023},
volume = {11},
number = {5},
doi = {10.1128/spectrum.00550-23}
}
EUVIMED